Ai Dozen
Papers
1
Total Citations
23
H-Index
1
About
Dr. Ai Dozen is a pioneering researcher at the intersection of epigenomics and clinical robotics, whose work is redefining how we analyze archival tissue samples. Her primary research areas include chromatin biology, cancer epigenetics, and the automation of genomic assays. Dr. Dozen’s major contribution is the development of a groundbreaking method for genome-wide chromatin analysis of formalin-fixed paraffin-embedded (FFPE) tissues, a notoriously difficult sample type. By integrating a dual-arm robot, she demonstrated that accurate transcription factor binding sites could be reliably retrieved from these preserved specimens—a feat previously considered elusive. This innovation, detailed in her most-cited 2021 paper (23 citations), holds immense clinical potential, enabling the retrospective study of gene regulation from vast biobanks of archived patient tissues. Her work bridges the gap between high-throughput genomics and practical pathology, offering a powerful tool for biomarker discovery and personalized medicine. Dr. Dozen’s achievements mark a significant step toward making comprehensive epigenetic profiling a routine part of clinical diagnostics.
Research Focus
Key Achievements
Top Papers
- 1